Skip to main content
Clinical Trials/NCT03298035
NCT03298035
Completed
Not Applicable

A Comparison of Non-invasive Ventilation Methods Used to Prevent Endotracheal Intubation Due to Apnea in Very Low Birth Weight Infants

The University of Texas Health Science Center, Houston1 site in 1 country19 target enrollmentNovember 11, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Apnea of Prematurity
Sponsor
The University of Texas Health Science Center, Houston
Enrollment
19
Locations
1
Primary Endpoint
Number of Participants Who Were Intubated
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The purpose of this study is to determine whether nasal intermittent positive pressure ventilation (NIPPV) reduces the need for endotracheal intubation in very low birth weight infants with persistent apnea who fail nasal continuous positive airway pressure (NCPAP).

Registry
clinicaltrials.gov
Start Date
November 11, 2017
End Date
December 31, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Catherine Claire Beaullieu

Neonatal-Perinatal Medicine Fellow

The University of Texas Health Science Center, Houston

Eligibility Criteria

Inclusion Criteria

  • Infants born at \< 30 weeks gestational age who develop clinically significant apnea while on NCPAP \> 6cm H2O or whose team is considering intubation due to apnea. Consider clinically significant apnea as 1 or more events treated with bag-mask ventilation or 3 episodes of apnea requiring stimulation within 1 hour.
  • Infants on maximum caffeine therapy (10mg/kg/day)

Exclusion Criteria

  • Major congenital anomalies including congenital heart disease

Outcomes

Primary Outcomes

Number of Participants Who Were Intubated

Time Frame: 28 days after randomization

Duration of Intubation

Time Frame: 28 days after randomization

Secondary Outcomes

  • Number of Apneic Events(28 days after randomization)
  • Number of Participants With Bronchopulmonary Dysplasia (BPD)(36 weeks corrected gestational age)
  • Length of Hospital Stay(about 10 to 18 weeks)
  • Number of Participants Who Died(until discharge (about 10 to 18 weeks) or death)
  • Number of Participants With Necrotizing Enterocolitis (NEC)(36 weeks corrected gestational age)
  • Number of Participants With Air Leak Disorders(36 weeks corrected gestational age)
  • Weight Gain(36 weeks corrected gestational age)

Study Sites (1)

Loading locations...

Similar Trials